Certain Supplements News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Certain Supplements. Real-time updates on events, politics, business and more.

Year in Review: Top Regulatory Developments of 2023 | Goodwin

January 26, 2024

As we kick off 2024, we reflect on regulatory developments in the biologics and biosimilars space in 2023. Below are some of the top regulatory developments from 2023.

Fresenius Kabi Coherus Biosciences Samsung Bioepis Boehringer Ingelheim Inflation Reduction Act Drug Price Negotiation Program Biologic License Applications

Source: jdsupra.com

FDA Issues Draft Guidance on Formal Meetings between the FDA and Sponsors or Applicants of BsUFA Products and Classification Categories for Certain Supplements under BsUFA III | Goodwin

August 16, 2023

In August 2023, the Food and Drug Administration issued two draft guidance, both related to the development of biosimilar products, entitled “Formal Meetings between the FDA and...

Product Development Drug Administration Certain Supplements Biosimilar Initial Advisory Biological Product Development Biosimilar User Fee Amendments

Source: jdsupra.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Certain Supplements News Today

Year in Review: Top Regulatory Developments of 2023 | Goodwin

FDA Issues Draft Guidance on Formal Meetings between the FDA and Sponsors or Applicants of BsUFA Products and Classification Categories for Certain Supplements under BsUFA III | Goodwin

Explore More Categories